AB0300 Association of vitamin d status with rheumatoid arthritis disease activity and uv index. (15th June 2017)

• Record Type: Journal Article
• Authors: Lopes, C; Gomes, JL; Costa, T; Mateus, M; Pimentel-Santos, F; Branco, JC
• Is Part Of: Annals of the rheumatic diseases. Volume 76(2017)Supplement 2
• Page Start: 1153
• Page End: 1154
• Publication Date: 2017-06-15
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2017-eular.4062
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Lower serum vitamin D levels have been shown to be associated with various autoimmune disorders, including Rheumatoid Arthritis (RA). Vitamin D deficiency is common in RA patients, despite profiting from a sunny country. Objectives: The aim of the study is to evaluate (1) – the association between vitamin D serum levels and disease activity in patients with RA; (2) – seasonal distribution of vitamin D levels. Methods: Patients fulfilling the 2010 EULAR/ACR Rheumatoid Arthritis Classification Criteria, which had serum vitamin D [25(OH)D3] levels measured between January 2013 and December of 2016 were included. Demographic data, disease activity scores, including DAS283v-CRP and DAS283v-ESR, vitamin D supplementation with cholecalciferol and other therapeutic approaches were recorded. Vitamin D insufficiency was considered between 25–75 nmol/L and deficiency if <25 nmol/L. According to the national agency for the study of sea and atmosphere, UV Index levels were grouped into low UV Index 3–6 (October to April) and high UV Index 9–10 (May to September). Correlation between variables was analyzed using Spearman's rho. Results: A sample composed by 95 patients, 79 females (83.16%), with an average age (SD) of 68.57 (11.92) years within 40–88 years range were included. Average disease duration was 13.46 (11.41) years. The average age at diagnosis was 57.10 (14.25) years. The average vitamin D levels were 78.13 (60.98) nmol/L in a range between 20–400 nmol/L. Vitamin D levels were not significantly different in male vs . females patients. The prevalence of vitamin D insufficiency and deficiency was 53.68% and 8.42% respectively, despite 57.89% of the patients taking supplementation (average 6141 (4800) UI/week). The univariable analysis showed that albeit vitamin D levels presented a negative poor correlation with DAS283v-CRP (rho=-0.348, p-value<0.001) and DAS283v-ESR (rho=-0.271, p-value<0.01), there was a direct reduction in dispersion of the vitamin D values for increasing values of DAS283v-CRP and ESR. It was observed that vitamin D levels increase with patient age and decrease with disease duration. Sazonality and supplementation didn't affect vitamin D levels in our population. Conclusions: Vitamin D insufficiency/deficiency was frequent among RA patients (62.1%), independently of seasonality or supplementation. An interesting pattern behavior was observed in this study, which indicates that the likelihood of encountering a very narrowband of vitamin D values for patients with high disease activity is very high, and thus, the forecast capability of vitamin D values for patients with increasingly active disease is quite good. Future research will aim at strengthening the statistical parameters of relevance, identifying and characterizing the more specific behaviours of this global pattern. Disclosure of Interest: None declared